TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors.

Elizabeth S Higgs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.